SpectraCure AB (publ) OMXSTO:SPEC:
SIGNS AGREEMENT WITH ROSTOCK HOSPITAL FOR PROSTATE CANCER STUDY
Spectracure Signs Agreement With Rostock Hospital For Prostate Cancer Study
Earlier from Spectracure Ab
- Spectracure To Get SEK 31.3 Mln If All TO5 Warrants Utilized
- Spectracure Q3 Net Loss SEK 35 Mln
- Spectracure Says Study Shows Significant PSA Reduction In Prostate Cancer Patients
- Spectracure Signs Agreement With Cheplapharm For Verteporfin Supply